{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:58:47Z","timestamp":1773766727811,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T00:00:00Z","timestamp":1300924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s10067-011-1726-1","type":"journal-article","created":{"date-parts":[[2011,3,23]],"date-time":"2011-03-23T05:48:01Z","timestamp":1300859281000},"page":"1007-1012","source":"Crossref","is-referenced-by-count":43,"title":["Infliximab for patients with neuro-Behcet's disease: case series and literature review"],"prefix":"10.1007","volume":"30","author":[{"given":"Afshin","family":"Borhani Haghighi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anahid","family":"Safari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Nazarinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Habibagahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeedeh","family":"Shenavandeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,24]]},"reference":[{"key":"1726_CR1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.nrl.0000156343.16797.c4","volume":"11","author":"A Borhani Haghighi","year":"2005","unstructured":"Borhani Haghighi A, Pourmand R, Nikseresht AR (2005) Neuro-Behcet disease: a review. Neurologist 11:80\u201389","journal-title":"Neurologist"},{"key":"1726_CR2","first-page":"1542","volume":"27","author":"A Borhani-Haghighi","year":"2006","unstructured":"Borhani-Haghighi A, Samangooie S, Ashjazadeh N, Nikseresht A, Shariat A, Yousefipour G, Safari A (2006) Neurological manifestations of Behcet's disease. Saudi Med J 27:1542\u20131546","journal-title":"Saudi Med J"},{"key":"1726_CR3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/ern.09.11","volume":"9","author":"A Borhani Haghighi","year":"2009","unstructured":"Borhani Haghighi A (2009) Treatment of neuro-Behcet's disease: an update. Expert Rev Neurother 9:565\u2013574","journal-title":"Expert Rev Neurother"},{"key":"1726_CR4","doi-asserted-by":"crossref","unstructured":"Arida A, Fragiadaki K, Giavri E, Sfikakis PP (2010) Anti-TNF agents for Behcet's disease: analysis of published data on 369 patients. Semin Arthritis Rheum. doi: 10.1016\/j.semarthrit.2010.09.002","DOI":"10.1016\/j.semarthrit.2010.09.002"},{"key":"1726_CR5","doi-asserted-by":"crossref","unstructured":"International Study Group for Behcet's Disease. Criteria for diagnosis of Behcet's disease. (1990) Lancet 335:1078\u20131080","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"1726_CR6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.clineuro.2007.10.005","volume":"110","author":"A Borhani Haghighi","year":"2008","unstructured":"Borhani Haghighi A, Safari A (2008) Anti-tumor necrotic factor antibody for treatment of neuro-Behcet's disease, a case report. Clin Neurol Neurosurg 110:315\u2013316","journal-title":"Clin Neurol Neurosurg"},{"key":"1726_CR7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/ard.62.3.280","volume":"62","author":"G Licata","year":"2003","unstructured":"Licata G, Pinto A, Tuttolomondo A, Banco A, Ciccia F, Ferrante A, Triolo G (2003) Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behcet's syndrome. Ann Rheum Dis 62:280\u2013281","journal-title":"Ann Rheum Dis"},{"key":"1726_CR8","first-page":"181","volume":"32","author":"H Sarwar","year":"2005","unstructured":"Sarwar H, McGrath H Jr, Espinoza LR (2005) Successful treatment of long-standing neuro-Behcet's disease with infliximab. J Rheumatol 32:181\u2013183","journal-title":"J Rheumatol"},{"key":"1726_CR9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/jnnp.2004.055434","volume":"76","author":"C Ribi","year":"2005","unstructured":"Ribi C, Sztajzel R, Delavelle J, Chizzolini C (2005) Efficacy of TNF(alpha) blockade in cyclophosphamide resistant neuro-Behcet disease. J Neurol Neurosurg Psychiatr 76:1733\u20131735","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"1726_CR10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clineuro.2006.11.002","volume":"109","author":"JE Alty","year":"2007","unstructured":"Alty JE, Monaghan TM, Bamford JM (2007) A patient with neuro-Behcet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade. Clin Neurol Neurosurg 109:279\u2013281","journal-title":"Clin Neurol Neurosurg"},{"key":"1726_CR11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.2006.056804","volume":"66","author":"K Fujikawa","year":"2007","unstructured":"Fujikawa K, Aratake K, Kawakami A, Aramaki T, Iwanaga N, Izumi Y, Arima K, Kamachi M, Tamai M, Huang M, Nakamura H, Nishiura Y, Origuchi T, Ida H, Eguchi K (2007) Successful treatment of refractory neuro-Behcet's disease with infliximab: a case report to show its efficacy by magnetic resonance imaging, transcranial magnetic stimulation and cytokine profile. Ann Rheum Dis 66:136\u2013137","journal-title":"Ann Rheum Dis"},{"key":"1726_CR12","first-page":"S133","volume":"26","author":"J Belzunegui","year":"2008","unstructured":"Belzunegui J, Lopez L, Paniagua I, Intxausti JJ, Maiz O (2008) Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behcet's disease. Clin Exp Rheumatol 26:S133\u2013S134","journal-title":"Clin Exp Rheumatol"},{"key":"1726_CR13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.23345","volume":"59","author":"N Pipitone","year":"2008","unstructured":"Pipitone N, Olivieri I, Padula A, D'Angelo S, Nigro A, Zuccoli G, Boiardi L, Salvarani C (2008) Infliximab for the treatment of neuro-Behcet's disease: a case series and review of the literature. Arthritis Rheum 59:285\u2013290","journal-title":"Arthritis Rheum"},{"key":"1726_CR14","first-page":"S128","volume":"26","author":"WY Madanat","year":"2008","unstructured":"Madanat WY, Madanat AY (2008) Worsening of osteomalacia in a patient successfully treated for neuro-Behcet's disease with infliximab. Clin Exp Rheumatol 26:S128\u2013S129","journal-title":"Clin Exp Rheumatol"},{"key":"1726_CR15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","volume":"272","author":"H Kikuchi","year":"2008","unstructured":"Kikuchi H, Aramaki K, Hirohata S (2008) Effect of infliximab in progressive neuro-Behcet's syndrome. J Neurol Sci 272:99\u2013105","journal-title":"J Neurol Sci"},{"key":"1726_CR16","first-page":"S147","volume":"28","author":"H Kikuchi","year":"2010","unstructured":"Kikuchi H, Asako K, Takayama M, Arinuma Y, Hirohata S (2010) Infliximab therapy for chronic progressive neuro-Behcet's disease: a four-year follow-up study. Clin Exp Rheumatol 28:S147\u2013S147","journal-title":"Clin Exp Rheumatol"},{"key":"1726_CR17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1756-185X.2009.01420.x","volume":"12","author":"GM Abalos-Medina","year":"2009","unstructured":"Abalos-Medina GM, Sanchez-Cano D, Ruiz-Villaverde G, Ruiz-Villaverde R, Quirosa Flores S, Raya Alvarez E (2009) Successful use of infliximab in a patient with neuro-Behcet's disease. Int J Rheum Dis 12:264\u2013266","journal-title":"Int J Rheum Dis"},{"key":"1726_CR18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10165-010-0332-4","volume":"20","author":"T Matsui","year":"2010","unstructured":"Matsui T, Ishida T, Tono T, Yoshida T, Sato S, Hirohata S (2010) An attack of acute neuro-Beh\u00e7et's disease during the course of chronic progressive neuro-Beh\u00e7et's disease: report of two cases. Mod Rheumatol 20:621\u2013626","journal-title":"Mod Rheumatol"},{"key":"1726_CR19","first-page":"S119","volume":"28","author":"A Al-araji","year":"2010","unstructured":"Al-araji A, Saip ASS, Constantinescu C, Akman-demir G, Arayssi T, Espinoza L, Findling O, Garcia F, Hirohata S, Keogan M, Lo Monaco A, Pay S, Ramo C, Van Laar J, Zandi M (2010) Treatment of neuro-Behcet's disease with infliximab. An International Multicentre Case-Series of 18 patients. Clin Exp Rheumatol 28:S119\u2013S119","journal-title":"Clin Exp Rheumatol"},{"key":"1726_CR20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","volume":"46","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H (2007) Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations. Rheumatology (Oxford) 46:736\u2013741","journal-title":"Rheumatology (Oxford)"},{"key":"1726_CR21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00403-009-0990-2","volume":"301","author":"E Alpsoy","year":"2009","unstructured":"Alpsoy E, Akman A (2009) Behcet's disease: an algorithmic approach to its treatment. Arch Dermatol Res 301:693\u2013702","journal-title":"Arch Dermatol Res"},{"key":"1726_CR22","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s10067-010-1414-6","volume":"29","author":"A Borhani Haghighi","year":"2010","unstructured":"Borhani Haghighi A, Safari A (2010) Proposing an algorithm for treatment of different manifestations of neuro-Behcet's disease. Clin Rheumatol 29:683\u2013686","journal-title":"Clin Rheumatol"},{"key":"1726_CR23","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0755-4982(05)84079-5","volume":"34","author":"N Lanthier","year":"2005","unstructured":"Lanthier N, Parc C, Scavennec R, Dhote R, Brezin AP, Guillevi L (2005) Infliximab in the treatment of posterior uveitis in Behcet's disease. Long term follow up in four patients. Presse M\u00e9d 34:916\u2013918","journal-title":"Presse M\u00e9d"},{"key":"1726_CR24","doi-asserted-by":"crossref","unstructured":"Borhani Haghighi A, Sarhadi S, Farahangiz S (2010) MRI findings of neuro-Behcet's disease. Clin Rheumatol. doi: 10.1007\/s10067-010-1650-9","DOI":"10.1007\/s10067-010-1650-9"},{"issue":"Pt 11","key":"1726_CR25","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Serdaroglu P, Tasci B (1999) Clinical patterns of neurological involvement in Behcet's disease: Evaluation of 200 patients. Brain 122(Pt 11):2171\u20132182","journal-title":"Brain"},{"key":"1726_CR26","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s00415-010-5454-2","volume":"257","author":"H Ideguchi","year":"2010","unstructured":"Ideguchi H, Suda A, Takeno M, Kirino Y, Ihata A, Ueda A, Ohno S, Baba Y, Kuroiwa Y, Ishigatsubo Y (2010) Neurological manifestations of Behcet's disease in Japan: a study of 54 patients. J Neurol 257:1012\u20131020","journal-title":"J Neurol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1726-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-011-1726-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1726-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T15:50:36Z","timestamp":1637423436000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-011-1726-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,24]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1726"],"URL":"https:\/\/doi.org\/10.1007\/s10067-011-1726-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,24]]}}}